| Product Code: ETC7487349 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Hong Kong pyruvate kinase import market saw significant growth in 2024, with Japan, China, USA, Netherlands, and Denmark emerging as the top exporting countries. The market concentration, as measured by the HHI, increased from moderate to high in 2024. The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 7.84%, while the growth rate from 2023 to 2024 spiked at 106.85%. This indicates a surge in demand for pyruvate kinase in Hong Kong, driven by imports from key countries, signaling a thriving market with opportunities for stakeholders.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Hong Kong Pyruvate Kinase Market Overview |
3.1 Hong Kong Country Macro Economic Indicators |
3.2 Hong Kong Pyruvate Kinase Market Revenues & Volume, 2021 & 2031F |
3.3 Hong Kong Pyruvate Kinase Market - Industry Life Cycle |
3.4 Hong Kong Pyruvate Kinase Market - Porter's Five Forces |
3.5 Hong Kong Pyruvate Kinase Market Revenues & Volume Share, By Drugs, 2021 & 2031F |
4 Hong Kong Pyruvate Kinase Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of pyruvate kinase deficiency in Hong Kong |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of pyruvate kinase disorders |
4.2.3 Technological advancements in diagnostic tools and treatment options for pyruvate kinase disorders |
4.3 Market Restraints |
4.3.1 High cost associated with diagnostic tests and treatments for pyruvate kinase deficiency |
4.3.2 Limited availability of specialized healthcare professionals for managing pyruvate kinase disorders |
5 Hong Kong Pyruvate Kinase Market Trends |
6 Hong Kong Pyruvate Kinase Market, By Types |
6.1 Hong Kong Pyruvate Kinase Market, By Drugs |
6.1.1 Overview and Analysis |
6.1.2 Hong Kong Pyruvate Kinase Market Revenues & Volume, By Drugs, 2021- 2031F |
6.1.3 Hong Kong Pyruvate Kinase Market Revenues & Volume, By Pyrukynd (Mitapivat), 2021- 2031F |
6.1.4 Hong Kong Pyruvate Kinase Market Revenues & Volume, By RPL301, 2021- 2031F |
7 Hong Kong Pyruvate Kinase Market Import-Export Trade Statistics |
7.1 Hong Kong Pyruvate Kinase Market Export to Major Countries |
7.2 Hong Kong Pyruvate Kinase Market Imports from Major Countries |
8 Hong Kong Pyruvate Kinase Market Key Performance Indicators |
8.1 Number of patients diagnosed with pyruvate kinase deficiency in Hong Kong |
8.2 Adoption rate of new diagnostic tools for pyruvate kinase disorders by healthcare providers in Hong Kong |
8.3 Number of research studies or clinical trials focusing on pyruvate kinase disorders in Hong Kong |
9 Hong Kong Pyruvate Kinase Market - Opportunity Assessment |
9.1 Hong Kong Pyruvate Kinase Market Opportunity Assessment, By Drugs, 2021 & 2031F |
10 Hong Kong Pyruvate Kinase Market - Competitive Landscape |
10.1 Hong Kong Pyruvate Kinase Market Revenue Share, By Companies, 2024 |
10.2 Hong Kong Pyruvate Kinase Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |